Concerns have been raised that some agents, including TNF-alpha inhibitors (TNFi), may impair the anti-tumor immune response (19, 20); however, investigations in melanoma murine models suggest TNF inhibition may actually augment anti-tumor immunity (21, 22). The gene discussed is TNF; the disease is melanoma.